Old Republic International Corporation Common Stock (ORI)

Total Costs & Expenses

$8.38B

TTM · Period ending: · USD

ORI logo

ORI Total Costs & Expenses

Latest reported$8.38B
ORI TTM Total Costs & Expenses ($542.10M → $8.38B)
High-resolution chart · PNG

ORI total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Old Republic International Corporation Common Stock Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
8,383,999,999
8,202,799,999
8,084,199,999
7,904,599,999
7,697,200,000
7,540,700,000
7,350,700,000
7,161,600,000
6,993,900,000
6,775,300,000
6,618,400,000
6,510,700,000
6,503,700,000
6,648,200,000
6,911,800,000
7,226,200,000
7,460,700,000
7,526,200,000
7,518,900,000
7,419,400,000
7,446,000,000
7,184,500,000
6,854,600,000
6,664,200,000
6,289,800,000
6,163,700,000
6,075,100,000
5,891,200,000
5,726,400,000
5,652,400,000
5,597,200,000
5,583,500,000
5,536,500,000
5,625,200,000
5,593,900,000
5,537,600,000
5,524,100,000
5,322,700,000
5,263,400,000
5,214,400,000
5,195,200,000
5,224,200,000
5,188,900,000
5,134,200,000
5,079,100,000
4,987,800,000
4,963,900,000
4,921,100,000
4,826,800,000
4,786,900,000
4,717,900,000
4,769,700,000
4,900,100,000
5,006,300,000
5,123,300,000
5,098,600,000
5,007,000,000
4,967,300,000
4,888,300,000
4,881,900,000
4,852,800,000
4,603,800,000
4,327,900,000
4,075,000,000
3,914,000,000
3,936,100,000
4,007,000,000
4,076,800,000
4,063,100,000
4,010,300,000
4,037,100,000
4,057,100,000
4,067,200,000
4,045,300,000
3,885,300,000
3,712,400,000
3,463,000,000
3,264,200,000
3,161,700,000
3,114,400,000
3,143,900,000
3,122,700,000
3,117,600,000
3,058,300,000
3,012,600,000
2,956,000,000
2,888,500,000
2,841,100,000
2,769,200,000
2,739,700,000
2,684,900,000
2,605,800,000
2,529,800,000
2,400,700,000
2,281,700,000
2,195,400,000
2,077,100,000
1,997,600,000
1,941,500,000
1,869,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.